Daniel B Peterson, MD | |
5301 Vernon Ave S, Edina, MN 55436-2303 | |
(952) 925-2200 | |
Not Available |
Full Name | Daniel B Peterson |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 5301 Vernon Ave S, Edina, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285626812 | NPI | - | NPPES |
864919700 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 36834 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Daniel B Peterson, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Daniel B Peterson, MD 5301 Vernon Ave S, Edina, MN 55436-2303 Ph: (952) 925-2200 |
News Archive
GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.
4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that initial safety and efficacy data from its ongoing Phase II Study with resminostat, a pan-Histone Deacetylase (HDAC) Inhibitor, in relapsed/refractory Hodgkin Lymphoma (HL) patients after high dose chemotherapy and autologous hematopoietic stem cell transplantation will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, USA.
Clinical Data, Inc. today announced operational and financial results for the first quarter ended June 30, 2010, noting key accomplishments including the acceptance of the Company's new drug application (NDA) for vilazodone by the U.S. Food and Drug Administration (FDA) and the successful completion of a public offering .
Scientists have identified a strain of antibiotic-resistant tuberculosis that thrives in the presence of rifampin, a front-line drug in the treatment of tuberculosis. The bacterium was identified in a patient in China and is described in a study by researchers at the Johns Hopkins Bloomberg School of Public Health, Chongqing Pulmonary Hospital, Lanzhou University and Fudan University.
Drowning is one of the biggest problems in the United States, and considering the number of people who will head to bodies of water to cool off this summer, we are entering the riskiest months.
› Verified 3 days ago
Michael Jerome Pane, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7600 France Ave S Ste 4100, Edina, MN 55435 Phone: 952-831-1551 Fax: 952-831-0725 | |
Ruth Sumana Potta, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5016 Kent Ave, Edina, MN 55436 Phone: 952-381-7177 | |
Amy S Daleiden, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7600 France Ave S Ste 4200, Edina, MN 55435 Phone: 524-281-4009 Fax: 952-428-1404 | |
Mary M Figueroa, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6363 France Ave S, Suite 525, Edina, MN 55435 Phone: 952-926-6489 Fax: 952-926-6501 | |
Stephen D. Meade, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5301 Vernon Ave S, Edina, MN 55436 Phone: 952-925-2200 | |
Dr. Molly B Gruber, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 5301 Vernon Ave S, Edina, MN 55436 Phone: 952-925-2200 | |
Dr. Jolene Kay Berg, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 308 Dearborn Court, Edina, MN 55343 Phone: 612-718-8984 Fax: 210-426-3787 |